RELAPSED/REFRACTORY IMMUNE THROMBOCYTOPENIA

Clinical trials for RELAPSED/REFRACTORY IMMUNE THROMBOCYTOPENIA explained in plain language.

Never miss a new study

Get alerted when new RELAPSED/REFRACTORY IMMUNE THROMBOCYTOPENIA trials appear

Sign up with your email to follow new studies for RELAPSED/REFRACTORY IMMUNE THROMBOCYTOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for stubborn blood disorder: old drug tested in new way

Disease control Recruiting now

This study is testing if a drug called bortezomib can help adults with a hard-to-treat form of immune thrombocytopenia (ITP), where the immune system attacks platelets. It aims to see if the drug can safely raise and maintain platelet counts in people whose ITP has come back or h…

Matched conditions: RELAPSED/REFRACTORY IMMUNE THROMBOCYTOPENIA

Phase: PHASE2 • Sponsor: Seoul National University Hospital • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

RELAPSED/REFRACTORY IMMUNE THROMBOCYTOPENIA

Get alerted when new RELAPSED/REFRACTORY IMMUNE THROMBOCYTOPENIA trials appear

New hope for stubborn blood disorder: old drug tested in new way